Pharmaceutical

Elpiscience and Astellas partner for new macrophage engagers

Elpiscience Biopharma has signed an agreement with Astellas Pharma for two new bispecific macrophage engagers for cancer.

Dec 28, 2023 - 18:00
Elpiscience and Astellas partner for new macrophage engagers
Elpiscience Biopharma has signed an agreement with Astellas Pharma for two new bispecific macrophage engagers for cancer.
Read the original article

Tags:

Previous Article

J&J jumps on ADC train, signs $1.7bn licensing deal with LegoChem

Next Article

ARTBIO divulges plans for proprietary isotope manufacturing technology

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Iruplinalkib by Qilu Pharmaceutical for Solid Tumor: Li...

Dec 22, 2023

Flagship Pioneering crosses the pond, opens a European front

Flagship Pioneering crosses the pond, opens a European ...

Nov 29, 2023

ImmunityBio partners with Serum Institute for BCG vaccines

ImmunityBio partners with Serum Institute for BCG vaccines

May 5, 2024